vs
Side-by-side financial comparison of COLONY BANKCORP INC (CBAN) and Neuronetics, Inc. (STIM). Click either name above to swap in a different company.
Neuronetics, Inc. is the larger business by last-quarter revenue ($41.8M vs $39.9M, roughly 1.0× COLONY BANKCORP INC). COLONY BANKCORP INC runs the higher net margin — 20.6% vs -17.2%, a 37.8% gap on every dollar of revenue. Over the past eight quarters, Neuronetics, Inc.'s revenue compounded faster (54.9% CAGR vs 19.6%).
Colony Bankcorp Inc is a US-based bank holding company that operates Colony Bank. It provides a full suite of personal and commercial banking services including deposit accounts, consumer and business loans, mortgage services, and wealth management solutions, primarily serving retail customers and small-to-medium enterprises across the state of Georgia.
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
CBAN vs STIM — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $39.9M | $41.8M |
| Net Profit | $8.2M | $-7.2M |
| Gross Margin | — | 52.0% |
| Operating Margin | — | -12.1% |
| Net Margin | 20.6% | -17.2% |
| Revenue YoY | — | 85.7% |
| Net Profit YoY | 24.1% | 43.2% |
| EPS (diluted) | — | $-0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $39.9M | — | ||
| Q4 25 | $36.9M | $41.8M | ||
| Q3 25 | $32.8M | $37.3M | ||
| Q2 25 | $32.5M | $38.1M | ||
| Q1 25 | $30.0M | $32.0M | ||
| Q4 24 | $30.8M | $22.5M | ||
| Q3 24 | $28.6M | $18.5M | ||
| Q2 24 | $27.9M | $16.4M |
| Q1 26 | $8.2M | — | ||
| Q4 25 | — | $-7.2M | ||
| Q3 25 | $5.8M | $-9.0M | ||
| Q2 25 | $8.0M | $-10.1M | ||
| Q1 25 | $6.6M | $-12.7M | ||
| Q4 24 | — | $-12.7M | ||
| Q3 24 | $5.6M | $-13.3M | ||
| Q2 24 | $5.5M | $-9.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | 52.0% | ||
| Q3 25 | — | 45.9% | ||
| Q2 25 | — | 46.6% | ||
| Q1 25 | — | 49.2% | ||
| Q4 24 | — | 66.2% | ||
| Q3 24 | — | 75.6% | ||
| Q2 24 | — | 74.0% |
| Q1 26 | — | — | ||
| Q4 25 | 25.9% | -12.1% | ||
| Q3 25 | 22.2% | -19.6% | ||
| Q2 25 | 30.9% | -21.1% | ||
| Q1 25 | 27.6% | -34.4% | ||
| Q4 24 | 28.8% | -51.0% | ||
| Q3 24 | 24.6% | -41.7% | ||
| Q2 24 | 24.8% | -51.7% |
| Q1 26 | 20.6% | — | ||
| Q4 25 | — | -17.2% | ||
| Q3 25 | 17.7% | -24.3% | ||
| Q2 25 | 24.6% | -26.6% | ||
| Q1 25 | 22.0% | -39.6% | ||
| Q4 24 | — | -56.4% | ||
| Q3 24 | 19.7% | -72.0% | ||
| Q2 24 | 19.6% | -59.8% |
| Q1 26 | — | — | ||
| Q4 25 | $0.42 | $-0.10 | ||
| Q3 25 | $0.33 | $-0.13 | ||
| Q2 25 | $0.46 | $-0.15 | ||
| Q1 25 | $0.38 | $-0.21 | ||
| Q4 24 | $0.43 | $-0.34 | ||
| Q3 24 | $0.32 | $-0.44 | ||
| Q2 24 | $0.31 | $-0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $295.8M | $28.1M |
| Total DebtLower is stronger | — | $65.8M |
| Stockholders' EquityBook value | $380.4M | $22.4M |
| Total Assets | $3.7B | $141.6M |
| Debt / EquityLower = less leverage | — | 2.94× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $295.8M | — | ||
| Q4 25 | — | $28.1M | ||
| Q3 25 | — | $28.0M | ||
| Q2 25 | — | $11.0M | ||
| Q1 25 | — | $20.2M | ||
| Q4 24 | — | $18.5M | ||
| Q3 24 | — | $20.9M | ||
| Q2 24 | — | $42.6M |
| Q1 26 | — | — | ||
| Q4 25 | $258.1M | $65.8M | ||
| Q3 25 | — | $65.7M | ||
| Q2 25 | — | $55.5M | ||
| Q1 25 | — | $55.3M | ||
| Q4 24 | $248.0M | $55.2M | ||
| Q3 24 | — | $46.0M | ||
| Q2 24 | — | $59.8M |
| Q1 26 | $380.4M | — | ||
| Q4 25 | $375.9M | $22.4M | ||
| Q3 25 | $302.3M | $27.4M | ||
| Q2 25 | $293.9M | $27.1M | ||
| Q1 25 | $286.9M | $35.5M | ||
| Q4 24 | $278.7M | $27.7M | ||
| Q3 24 | $276.1M | $9.4M | ||
| Q2 24 | $264.7M | $19.4M |
| Q1 26 | $3.7B | — | ||
| Q4 25 | $3.7B | $141.6M | ||
| Q3 25 | $3.2B | $145.5M | ||
| Q2 25 | $3.1B | $134.7M | ||
| Q1 25 | $3.2B | $142.0M | ||
| Q4 24 | $3.1B | $140.9M | ||
| Q3 24 | $3.1B | — | ||
| Q2 24 | $3.0B | $96.8M |
| Q1 26 | — | — | ||
| Q4 25 | 0.69× | 2.94× | ||
| Q3 25 | — | 2.40× | ||
| Q2 25 | — | 2.05× | ||
| Q1 25 | — | 1.56× | ||
| Q4 24 | 0.89× | 1.99× | ||
| Q3 24 | — | 4.90× | ||
| Q2 24 | — | 3.08× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $908.0K |
| Free Cash FlowOCF − Capex | — | $692.0K |
| FCF MarginFCF / Revenue | — | 1.7% |
| Capex IntensityCapex / Revenue | — | 0.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-21.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-5.5M | $908.0K | ||
| Q3 25 | $14.4M | $-785.0K | ||
| Q2 25 | $15.8M | $-3.5M | ||
| Q1 25 | $17.9M | $-17.0M | ||
| Q4 24 | $23.4M | $-8.6M | ||
| Q3 24 | $20.5M | $-5.4M | ||
| Q2 24 | $1.1M | $-5.0M |
| Q1 26 | — | — | ||
| Q4 25 | $-6.9M | $692.0K | ||
| Q3 25 | $14.1M | $-899.0K | ||
| Q2 25 | $15.8M | $-3.8M | ||
| Q1 25 | $17.6M | $-17.2M | ||
| Q4 24 | $22.3M | $-8.7M | ||
| Q3 24 | $20.2M | $-5.8M | ||
| Q2 24 | $990.0K | $-5.6M |
| Q1 26 | — | — | ||
| Q4 25 | -18.7% | 1.7% | ||
| Q3 25 | 42.9% | -2.4% | ||
| Q2 25 | 48.5% | -9.9% | ||
| Q1 25 | 58.7% | -53.8% | ||
| Q4 24 | 72.5% | -38.6% | ||
| Q3 24 | 70.6% | -31.3% | ||
| Q2 24 | 3.5% | -34.0% |
| Q1 26 | — | — | ||
| Q4 25 | 3.7% | 0.5% | ||
| Q3 25 | 1.1% | 0.3% | ||
| Q2 25 | 0.3% | 0.7% | ||
| Q1 25 | 1.2% | 0.7% | ||
| Q4 24 | 3.5% | 0.4% | ||
| Q3 24 | 1.0% | 2.1% | ||
| Q2 24 | 0.5% | 3.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 2.48× | — | ||
| Q2 25 | 1.99× | — | ||
| Q1 25 | 2.71× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.64× | — | ||
| Q2 24 | 0.20× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBAN
| Net Interest Income | $29.2M | 73% |
| Noninterest Income | $10.7M | 27% |
STIM
Segment breakdown not available.
